Geneos Wealth Management’s Vuzix VUZI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$580 Buy
+200
New +$630 ﹤0.01% 2464
2026
Q1
Sell
-200
Closed -$756 2567
2025
Q4
$756 Hold
200
﹤0.01% 2430
2025
Q3
$626 Hold
200
﹤0.01% 2446
2025
Q2
$584 Buy
+200
New +$472 ﹤0.01% 3089
2025
Q1
Sell
-200
Closed -$788 3157
2024
Q4
$788 Buy
+200
New +$410 ﹤0.01% 2822
2023
Q3
Sell
-108
Closed -$551 2145
2023
Q2
$551 Buy
+108
New +$478 ﹤0.01% 2065
2018
Q3
Sell
-1,900
Closed -$14K 2457
2018
Q2
$14K Hold
1,900
﹤0.01% 1590
2018
Q1
$10K Sell
1,900
-100
-5% -$816 ﹤0.01% 1661
2017
Q4
$12K Hold
2,000
﹤0.01% 1579
2017
Q3
$10K Hold
2,000
﹤0.01% 1588
2017
Q2
$13K Hold
2,000
﹤0.01% 1447
2017
Q1
$12K Hold
2,000
﹤0.01% 1435
2016
Q4
$13K Hold
2,000
﹤0.01% 1359
2016
Q3
$17K Buy
2,000
+100
+5% +$805 ﹤0.01% 1196
2016
Q2
$15K Hold
1,900
﹤0.01% 1208
2016
Q1
$10K Buy
+1,900
New +$10.8K ﹤0.01% 1317

Other funds holding VUZI

Geneos Wealth Management's VUZI Position: Q2 2026 in Review

Geneos Wealth Management opened a new position in Vuzix (VUZI) in Q2 2026: 200 shares worth $580. The stake represents ﹤0.01% of the portfolio and ranks #2464 among its holdings. This is a return to the name: Geneos Wealth Management previously reported a position in VUZI as recently as Q4 2025.

Geneos Wealth Management first reported a position in VUZI in Q1 2016 and has held it in 16 quarters since. The position peaked at $17K in Q3 2016. 127 funds tracked by Wall St. Rank hold VUZI as of Q2 2026.

  • Geneos Wealth Management held 200 shares of Vuzix worth $580 as of Q2 2026.
  • Vuzix was a new Geneos Wealth Management position in Q2 2026.
  • Vuzix made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #2464 holding.
  • Geneos Wealth Management first reported a position in Vuzix in Q1 2016 and has held it in 16 quarters since.
  • Geneos Wealth Management's Vuzix position peaked at $17K in Q3 2016.
  • 127 funds tracked by Wall St. Rank held Vuzix as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.